Satellos Bioscience Inc（MSLE）價格預測

$6.350

-0.117 (-1.85%)收盤時

價格預測

1-Day Price Prediction

+3.72%

1-Week Prediction

-1.86%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

在 App 中開啟以解鎖更長週期的預測。

Loading chart…

MSLE 相似圖表分析預測

Alphio's MSLE stock price prediction model matches the current Satellos Bioscience Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $6.59 (+3.72%). The 1-week path is $6.23 (-1.86%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

該買進 Satellos Bioscience Inc 股票嗎？

Currently, Satellos Bioscience Inc (MSLE) is trading at $6.40, which is significantly lower than its 52-week high of $13.39, indicating a potential undervaluation. However, the stock has a low Relative Strength Index (RSI) of 37.87, suggesting it is nearing oversold territory but may still face downward pressure. The company has received FDA Fast Track Designation for its drug SAT-3247, which could enhance its market competitiveness and drive future growth. The primary risk is the projected earnings per share (EPS) of -0.44 for the next quarter, which indicates continued losses. Overall, while there are positive catalysts, the current financial performance and technical indicators suggest a cautious approach, making it a hold for now.